Nigrostriatal neuronal death following chronic dichlorvos exposure: Crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Binukumar, B K ^a   Bal, Amanjit ^a   Kandimalla, Ramesh J L ^a   Gill, Kiran Dip ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DICHLORVOS; DOPAMINE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; INSECTICIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CATALEPSY; CELL SWELLING; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DISEASE EXACERBATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; DYSTROPHY; ENZYME ACTIVITY; LIPID PEROXIDATION; LONG TERM EXPOSURE; MALE; MITOCHONDRION; MOLECULAR INTERACTION; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEURITE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; SUBSTANTIA NIGRA; ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; CELL NUCLEUS; CORPUS STRIATUM; DICHLORVOS; HUMANS; INSECTICIDES; MALE; MITOCHONDRIA; NEURONS; NEUROPSYCHOLOGICAL TESTS; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; UBIQUITIN;

EID: 78649903669     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-35     Document Type: Article

References (61)

1. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. DC Wu P Teismann K Tieu M Vila V Jackson-Lewis H Ischiropoulos S Przedborski, Proc Natl Acad Sci USA 2003 100 6145 6150 10.1073/pnas.0937239100 12721370
2. Association between Parkinson's disease and exposure to pesticides in southwestern France. I Baldi A Cantagrel P Lebailly F Tison B Dubroca V Chrysostome JF Dartigues P Brochard, Neuroepidemiology 2003 22 305 10 10.1159/000071194 12902626
3. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. R Betarbet TB Sherer G MacKenzie M Garcia-Osuna AV Panov JT Greenamyr, Nat Neurosci 2003 12 1301 1306
4. Case-control study of Parkinson's disease in a horticultural region of British Columbia. C Hertzman M Wiens MB Snow SA Kelly, Mov Disorder 1994 9 69 75 10.1002/mds.870090111
5. The role of environmental toxins in the etiology of Parkinson's disease. CM Tanner, Trends in Neuroscience 1989 12 49 54 10.1016/0166-2236(89)90135-5
6. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. SC Li BS Schoenberg CC Wang XM Cheng DY Rui CL Bolis, Arch Neurol 1985 42 655 657 4015461
7. Environmental factors and Parkinson's disease: a case control-study in China. CM Tanner B Chen W Wang, Neurology 1989 39 660 664 2710356
8. Epidemiologic study of Parkinson's disease in Hong Kong. S Ho J Woo C Lee, Neurology 1989 39 1314 18 2797455
9. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. AL McCormack M Thiruchelvam AB Manning-Bog C Thiffault DA Cory-Slechta DA Di Monte, Neurobiol Dis 2002 10 119 127 10.1006/nbdi.2002.0507 12127150
10. Parkinson's disease risk factors: genetic, environmental, or both? MF Allam AS Del Castillo RF Navajas, Neurol Res 2005 27 206 208 10.1179/016164105X22057 15829184
11. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. P Kaur B Radotra RW Minz KD Gill, Neurotoxicology 2007 28 1208 1219 10.1016/j.neuro.2007.08.001 17850875
12. Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos. BK Binukumar A Bal R Kandimalla A Sunkaria KD Gill, Toxicology 2010 270 77 84 10.1016/j.tox.2010.01.017 20132858
13. Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. S Choudhary G Raheja V Gupta KD Gill, J Biochem Mol Biol Biophys 2002 6 29 36 10.1080/10258140290010197 12186780
14. Toxicity of dermally absorbed dichlorvos in rats. S Luty J Latuszynska J Halliop A Tochman D Obuchowska E Przylepa E Korczak E Bychawski, Ann Agric Environ Med 1998 5 57 64 9852492
15. Alpha-synuclein aggregation and neurodegenerative diseases. QL Ma P Chan M Yoshii K Uéda, J Alzheimers Dis 2003 5 2 139 48 12719631
16. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Y Izuno S Ohta M Tanaka S Takamiya K Suzuki T Sato, Biochem Biophys Res Commun 1989 163 1450 5 10.1016/0006-291X(89)91141-8 2551290
17. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. WD Parker SJ Boyson JK Parks, Ann Neurol 1989 26 719 23 10.1002/ana.410260606 2557792
18. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. JA Javitch RJ D'Amato SM Strittmatter SH Snyder, Proc Natl Acad Sci USA 1985 82 2173 2173 10.1073/pnas.82.7.2173 3872460
19. Neurodegeneration in Parkinson's disease. CW Olanow P Jenner N Tatton WG Tatton, Parkinson's Disease and Movement Disorders Baltimore, MD: Williams & Wilkins, Jankovic J, Tolosa E, 3 1988 67 103
20. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. K Sriram KS Pai MR Boyd V Ravindranath, Brain Res 1997 749 44 52 10.1016/S0006-8993(96)01271-1 9070626
21. Novel free radical spin traps protect against malonate and MPTP neurotoxicity. RT Matthews P Klivenyi G Mueller L Yang M Wermer CE Thomas MF Beal, Exp Neurol 1997 157 120 126 10.1006/exnr.1999.7045
22. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease. AG Kanthasamy M Kitazawa Y Yang V Anantharam A Kanthasamy, Mol Brain 2008 1 12 10.1186/1756-6606-1-12 18945348
23. Environment, mitochondria, and Parkinson's disease. TB Sherer R Betarbet JT Greenamyre, J Neuroscientist 2002 8 192 97
24. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. PA Trimmer RH Swerdlow JK Parks P Keeney JP Bennett SW Miller RE Davis WD Parker, Exp Neurol 2000 162 37 50 10.1006/exnr.2000.7333 10716887
25. Mitochondrial abnormalities in nigral neurons of the marmoset and Macaca fascicularis treated with MPTP. AC Levi R Ravazzani M de Mattei, Panminerva Med 1994 36 53 56 7831058
26. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. W Duan VM Rangnekar MP Mattson, J Neurochem 1999 72 2312 2322 10.1046/j.1471-4159.1999.0722312.x 10349840
27. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. P Anglade S Vyas EC Hirsch Y Agid, Histol Histopathol 1997 12 603 6010 9225140
28. Environmental and genetic factors in the etiology of Parkinson's disease. A Barbeau M Roy T Cloutier L Plasse, Advances in Neurology New York: Raven Press, Yahr, Bergmann, 1986 45 299 306
29. Bcl-2 gene family in the nervous system. DE Merry SJ Korsmeyer, Annu Rev Neurosci 1997 20 245 67 10.1146/annurev.neuro.20.1.245 9056714
30. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. S Kanda JF Bishop MA Eglitis Y Yang MM Mouradian, Neuroscience 2000 97 2 279 84 10.1016/S0306-4522(00)00077-4 10799759
31. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. OM El-Agnaf R Jakes MD Curran A Wallace, FEBS Lett 1998 440 1-2 67 70 10.1016/S0014-5793(98)01419-7 9862427
32. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. L Qiao S Hamamichi KA Caldwell GA Caldwell TA Yacoubian S Wilson ZL Xie LD Speake R Parks D Crabtree Q Liang S Crimmins L Schneider, Mol Brain 2008 1 17 10.1186/1756-6606-1-17 19021916
33. alpha-Synuclein locus triplication causes Parkinson's disease. AB Singleton M Farrer J Johnson A Singleton S Hague, Science 2003 302 5646 841 10.1126/science.1090278 14593171
34. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. XL Gu CX Long L Sun C Xie X Lin H Cai, Mol Brain 2010 3 12 10.1186/1756-6606-3-12 20409326
35. Membrane-bound alpha-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form. Lee He-Jin Choi Chan Lee Seung-Jae, J Biochem 2002 277 1 671 678
36. Oxidative stress induces amyloid-like aggre- gate formation of NACP/alpha-synuclein in vitro. M Hashimoto LJ Hsu Y Xia A Takeda A Sisk M Sundsmo E Masliah, Neuroreport 1999 10 717 21 10.1097/00001756-199903170-00011 10208537
37. Induction of alpha-synuclein aggregation by intracellular nitrative insult. E Paxinou Q Chen M Weisse BI Giasson EH Norris SM Rueter JQ Trojanowski VM Lee HJ Ischiropoulos, Neurosci 2001 21 8053 61
38. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. JM Souza BI Giasson Q Chen VM Lee H Ischiropoulos, J Biol Chem 2000 275 18344 49 10.1074/jbc.M000206200 10747881
39. Oxidative damage linked to neurodegeneration by selective alpha- synuclein nitration in synucleinopathy lesions. BI Giasson JE Duda IV Murray Q Chen JM Souza HI Hurtig H Ischiropoulos JQ Trojanowski VM Lee, Science 2000 290 985 89 10.1126/science.290.5493.985 11062131
40. NACP a protein implicated in Alzheimer's disease and learning, is natively unfolded. PH Weinreb W Zhen AW Poon KA Conway PT Lansbury, Biochemistry 1996 35 13709 715 10.1021/bi961799n 8901511
41. Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. VN Uversky J Lee H J Li AL Fink SJ Lee, J BiolChem 2001 276 43495 43498
42. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. VN Uversky J Li AL Fink, J Biol Chem 2001 276 10737 744 10.1074/jbc.M010907200 11152691
43. Degradation of alpha-synuclein by proteasome. MC Bennett JF Bishop Y Leng PB Chock TN Chase MM Mouradian, J Biol Chem 1999 274 33855 58 10.1074/jbc.274.48.33855 10567343
44. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. H Shimura MG Schlossmacher N Hattori MP Frosch A Trockenbacher R Schneider Y Mizuno KS Kosik DJ Selkoe, Science 2001 293 263 269 10.1126/science.1060627 11431533
45. The Rat Brain in Stereotaxic Coordinates. G Paxinos C Watson, Academic Press, London 1986
46. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. SB Berman TG Hastings, J Neurochem 1997 73 1127 1137 10.1046/j.1471-4159.1999.0731127.x
47. Preparation and properties of soluble NADH dehydrogenase from cardiac muscle. TE King RL Howard, Methods in Enzymology. Acad. Press, New York, Colowick SP, Kaplan NO, 1967 275 276
48. An electron transport system associated with the outer membrane of liver mitochondria. GL Sottocassa B Kuylenstierna L Ernster A Bergstrand, J Cell Biol 1967 32 415 438 10.1083/jcb.32.2.415 10976232
49. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. S Beretta G Sala L Mattavelli C Ceresa A Casciati A Ferri MT Carr C Ferrarese, Neurobiol Dis 2003 13 213 221 10.1016/S0969-9961(03)00043-3 12901835
50. Mechanisms of lipid peroxide formation in animal tissues. ED Wills, J Biochem 1966 99 667 676
51. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. LA MacMillan-Crow JP Crow JD Kerby JS Beckman JA Thompson, Proc Natl Acad Sci USA 1966 93 11853 11858 10.1073/pnas.93.21.11853
52. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. DA Gayle Z Ling C Tong T Landers JW Lipton PM Carvey, Brain Res Dev Brain Res 2002 133 27 35 10.1016/S0165-3806(01)00315-7 11850061
53. A new and rapid colorimetric determination of acetylcholinesterase activity. GL Ellman KD Courtney VJR Andres RM Feather-Stone, Biochem Pharmacol 1961 7 88 95 10.1016/0006-2952(61)90145-9 13726518
54. The isolation and characterization of dihydropteridine reductase from sheep liver. JE Craine ES Hall S Kaufman, J Biol Chem 1972 247 6082 91 4405600
55. Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. R Shiman M Akino S Kaufman, J Biol Chem 1971 246 1330 40 5545077
56. Dopamine beta-hydroxylase activity in stroke-prone spontaneously hypertensive rats. T Kato T Nagatsu Y Hashimoto Y Numata-Sudo Y Yamori K Okamoto, Jpn Heart J 1978 19 4 641 731912
57. An amine oxidase innormal human serum. Mcewen JD Cohen, J Lab Clin Med 1963 62 766 76 14078013
58. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. M Bishnoi K Chopra SK Kulkarni, Eur J Pharmacol 2006 552 55 66 10.1016/j.ejphar.2006.09.010 17064683
59. Handbook of Experimental Pharmacology. SK Kulkarni, Vallabh Prakashan, Delhi 3 1999
60. Effect of BR-16A (Mentat), a poly herbal formulation on drug induced catalepsy in mice. SK Kulkarni S Anil Kumar, Ind J Exp Biol 2006 44 45 48
61. Protein measurement with the folin-phenol reagent. OH Lowry NJ Rosebrough AL Farr RJ Randall, J Biol Chem 1951 193 265 75 14907713